Achieve Life Sciences

This phase 3 trial tests whether a drug called cytisinicline, taken three times daily for 12 weeks, can help adults stop using nicotine e-cigarettes. About 800 daily vapers will receive either the drug or a placebo, plus behavioral support. The goal is to see if more people can q…